http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2007240758-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6559372bde7c7c71d22286457328c86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e8cc3701ed4c4f042a7b88ebff70203
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-624
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02
filingDate 2007-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcfc511053d675da648d61168f605817
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2730cd2e3d642bced95b018202371037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_251522d7f461c99554043726c9b4a3b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c7a44eb9b5c85afd4aa63d0392e3ba5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_567af95f30f0f6ad11c600693aa4430f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d540cf862fe25178e9399ac926daabbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12ef63d98e6cb77c91852a1d807a30ba
publicationDate 2013-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2007240758-C1
titleOfInvention Magnetic targeting and sequestering of therapeutic formulations
abstract A therapeutic system and a method that use stents, and/or other implantable devices, for local delivery of a therapeutic agent is disclosed. A therapeutic formulation may include particles of a biocompatible magnetic or magnetizable material that carry the therapeutic agent, or magnetically responsive cells. The therapeutic formulation is intravenously administered to a mammalian subject. A portion of the formulation is delivered to the proximity of a device implanted in the vascular system of the subject by externally generating a magnetic field gradient on the implantable device. The portion of the therapeutic formulation not delivered to the proximity of the implantable device is removed from the vascular system. The method allows for the repeated administration of the same or different therapeutic agent, and, further, has the option of locally injecting, or alternatively, peripherally administering, the therapeutic agent.
priorityDate 2006-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02072172-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005110395-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19241
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJD2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100034206
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID558311
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10085
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJC5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601108
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID213
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280717
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID408047
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24186
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3T478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397731
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10085
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID793949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426184689
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID272636
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID247744
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID272636
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID781334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11838331
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID85302
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009195
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81814
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7114
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11657
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID399438

Total number of triples: 59.